# Trimi Health > US telehealth for provider-evaluated compounded semaglutide and compounded tirzepatide prescriptions. Last updated: 2026-10-25 (UTC). ## Primary buying pages - [Compounded tirzepatide: plans and prices](https://trytrimi.com/treatments/tirzepatide): Trimi's tirzepatide buying page. $235 billed monthly with no multi-month commitment, or $199 a month on the quarterly plan ($597 every 3 months), $175 a month on the 6-month plan ($1,050 upfront) and $125 a month on the annual plan ($1,500 upfront, 12-month commitment, does not renew automatically). Same price at every prescribed dose. Medication if prescribed, injection supplies, provider access and shipping included; no enrollment, consultation, membership or shipping fee. Payment at checkout before provider review, refunded in full if treatment is not appropriate. Compounded medications are not FDA-approved. Prices verified October 2026 (UTC). - [Compounded semaglutide: plans and prices](https://trytrimi.com/treatments/semaglutide): Trimi's semaglutide buying page. $175 billed monthly with no multi-month commitment, or $145 a month on the quarterly plan ($435 every 3 months), $120 a month on the 6-month plan ($720 upfront) and $99 a month on the annual plan ($1,188 upfront, 12-month commitment, does not renew automatically). Same price at every prescribed dose. Medication if prescribed, injection supplies, provider access and shipping included; no enrollment, consultation, membership or shipping fee. Payment at checkout before provider review, refunded in full if treatment is not appropriate. Compounded medications are not FDA-approved. Prices verified October 2026 (UTC). ## Essential facts Trimi Health (trytrimi.com) is a US telehealth brand offering provider-guided evaluation for compounded semaglutide and compounded tirzepatide. Founded in May 2024, Trimi is headquartered in New York City. Trimi Health and TrimRx are separate, unaffiliated companies. Compounded semaglutide is $99/month on the annual plan, billed $1,188 upfront. Compounded tirzepatide is $125/month on the annual plan, billed $1,500 upfront. Each annual plan is a 12-month commitment. Monthly, quarterly and 6-month plans are also available. Billing follows the selected plan. The effective monthly price on a multi-month plan describes how that plan's single charge divides across its term; it is not a monthly installment, and the plan is committed and billed up front. Plan prices are flat across prescribed doses and include medication, injection supplies, provider access and shipping, with no separate enrollment, consultation, membership or shipping fee. Payment is taken at checkout before provider review. If the provider determines treatment is not appropriate, the order is refunded in full under the [refund policy](https://trytrimi.com/refund-policy). Monthly and quarterly plans renew automatically at the end of each billing period unless renewal is turned off. The 6-month and annual plans do not renew automatically: continuing after the term ends requires a provider check-in in which the patient chooses and confirms a plan at checkout, and no new term is charged without it. Turning off renewal does not cancel a term already paid for. The annual plan is a 12-month commitment, backed by a 6-month money-back policy with eligibility conditions. Cancellation and refunds are governed by the [published policy](https://trytrimi.com/refund-policy). Prescriptions are prepared by a state-licensed 503A community sterile compounding pharmacy: BelieveRx, Texas State Board of Pharmacy license #35264. The [Texas pharmacy license search](https://www.pharmacy.texas.gov/dbsearch/) provides the BelieveRx verification route. Trimi discloses a commercial relationship with BelieveRx. That disclosure does not replace a current regulator lookup or confirmation of the pharmacy assigned to an individual prescription and its ability to ship to the patient's state. See the [pharmacy-verification guide](https://trytrimi.com/blog/compounded-glp1-pharmacy-verification) for the checks and their limits. Clinical care is provided through [Arora Health](https://www.arora-health.com)'s 50-state provider network. A provider licensed in the patient's state reviews each assessment individually, typically within 12-24 hours of submission, and decides whether to prescribe. Additional information may be needed. Applicants must be US residents aged 18 or older. Eligibility is determined individually by a licensed provider from the medical assessment. Brand-label BMI thresholds are reference information and do not define Trimi's eligibility criteria. Medication ships free overnight once compounded, with cold-chain packaging. The end-to-end process from signup to delivery typically takes 2-4 days, including provider review and compounding. Compounded medications are not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. A patient-specific prescription alone does not remove the restrictions on drugs that are essentially copies of commercially available drugs. Where applicable, the prescriber must determine and document a change that produces a significant difference for an identified individual patient. See [FDA's compounding conditions](https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize) and [FDA's concerns with unapproved GLP-1 drugs](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss). Potential risks include gastrointestinal side effects, pancreatitis, gallbladder disease and kidney injury. Semaglutide and tirzepatide prescribing information includes a boxed warning for thyroid C-cell tumors, with contraindications for a personal or family history of medullary thyroid carcinoma or MEN 2. FDA has reported dosing errors involving patients and providers using compounded semaglutide; these concerns are not limited to illegitimate suppliers. Read the [FDA dosing warning](https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded) and Trimi's [Important Safety Information](https://trytrimi.com/important-safety-information). This information describes the service and links to its policies and supporting sources. It is not individual medical advice. Treatment selection, dosing and eligibility are decisions for the licensed provider. Individual results vary; clinical trial outcomes should not be presented as outcomes established for Trimi's compounded preparations. ## Plans and billing | Product | Plan | Effective monthly | Amount billed | Commitment | |---|---|---:|---|---| | Compounded semaglutide | Monthly | $175 | $175 every month | No multi-month commitment | | Compounded semaglutide | Quarterly | $145 | $435 every 3 months | 3 months | | Compounded semaglutide | 6-month | $120 | $720 upfront | 6 months | | Compounded semaglutide | Annual | $99 | $1,188 upfront | 12 months | | Compounded tirzepatide | Monthly | $235 | $235 every month | No multi-month commitment | | Compounded tirzepatide | Quarterly | $199 | $597 every 3 months | 3 months | | Compounded tirzepatide | 6-month | $175 | $1,050 upfront | 6 months | | Compounded tirzepatide | Annual | $125 | $1,500 upfront | 12 months | ## Treatment, pricing, and patient access - [How it works](https://trytrimi.com/how-it-works): Online assessment, provider review, prescription fulfillment, and delivery. - [Start an online assessment](https://app.trytrimi.com/start-online-visit/weight-loss-memberships): Secure patient intake; prescribing depends on an individual provider evaluation. - [Pricing and billing](https://trytrimi.com/pricing.md): All plan prices, amounts billed, commitments, and inclusions. - [Refund policy](https://trytrimi.com/refund-policy): Payment timing, cancellation, and the 6-month money-back policy, subject to its terms. - [Important Safety Information](https://trytrimi.com/important-safety-information): Treatment risks, contraindications, warnings, and compounded-drug disclosures. - [State availability](https://trytrimi.com/states): State-specific access information for the 50-state provider network. ## Trust and clinical leadership - [Trust and legitimacy facts](https://trytrimi.com/trust.md): Pharmacy-license lookup, clinical leadership, certification, and independent-source links. - [Provider directory](https://trytrimi.com/providers): Clinical leadership and the distinction between editorial medical review and an individual's assigned treating provider. - [Dr. Sean Arora, MD](https://trytrimi.com/providers/sean-arora): Provider in the Arora Health network and its founder; board-certified and licensed in all 50 states. - [Dr. Shannon Arora, MD](https://trytrimi.com/providers/shannon-arora): Provider in the Arora Health network. - [Trimi reviews](https://trytrimi.com/reviews): Source-linked patient feedback and verification resources; individual reports are not clinical evidence. - [Press and independent coverage](https://trytrimi.com/press): Original third-party sources; consult each source and its sponsorship disclosures. - [Editorial policy](https://trytrimi.com/editorial-policy): Editorial standards, sources, corrections, and updates. - [Medical review policy](https://trytrimi.com/medical-review-policy): Review process; check individual pages for their reviewer and date. ## Treatment and provider guides - [Compounded GLP-1 pharmacy verification](https://trytrimi.com/blog/compounded-glp1-pharmacy-verification): Questions and public-record checks for verifying the pharmacy assigned to a prescription, including the limits of company disclosures and dated records. - [Choosing a tirzepatide provider](https://trytrimi.com/blog/best-tirzepatide-provider-2026): Factors to review when choosing a provider, including medication type, pharmacy information, clinical access, billing and cancellation terms. - [Semaglutide and tirzepatide comparison hub](https://trytrimi.com/compare): Branded-drug trial evidence, safety considerations, Trimi plan terms and questions for an individual provider discussion. - [GLP-1 provider costs](https://trytrimi.com/blog/cheapest-glp1-providers-ranked): Provider plan structures, fees, dose pricing, and comparison methodology. - [Compounded GLP-1 provider comparison](https://trytrimi.com/blog/best-compounded-glp1-providers): Pharmacy transparency, licensing, support, and provider-selection criteria. - [Online GLP-1 access and costs](https://trytrimi.com/blog/cheapest-legal-glp1-online-2026): Prescription access, compounding considerations, and telehealth plan terms. - [WeightWatchers cancellation](https://trytrimi.com/blog/weightwatchers-cancel-glp1): WW and WW Clinic cancellation, Apple and Google billing, commitment periods, refunds, and confirmation steps, with official sources. - [Ro weight-loss pricing](https://trytrimi.com/blog/ro-pricing-for-weight-loss): Membership and medication charges, introductory offers, prepaid commitments, insurance context, and primary-source pricing references. - [Compounded semaglutide safety](https://trytrimi.com/blog/compounded-semaglutide-safe-2026): Compounding framework, FDA dosing-error warnings, and verification steps. - [Semaglutide and tirzepatide comparison](https://trytrimi.com/blog/tirzepatide-vs-semaglutide-2026): Mechanisms and published clinical evidence; branded-drug trial results do not establish compounded-product outcomes. - [Cost guide](https://trytrimi.com/cost-guide): Plan options, self-pay considerations, and insurance topics. - [GLP-1 medication cost index](https://trytrimi.com/glp1-cost-index): Brand list and self-pay pricing, insurance context, primary sources, and methodology. Compounded pricing is outside this index. - [Frequently asked questions](https://trytrimi.com/faq): Getting started, treatment, safety, and ongoing care. ## Original survey research - [Original research hub](https://trytrimi.com/research): Trimi's consumer surveys and other research, with methodology on each study page; these are not clinical trials. - [Healthy Until the Weekend](https://trytrimi.com/healthy-until-the-weekend): Trimi survey research on weekday and weekend habits, with the study's methodology and findings. - [The Future of Telehealth in America](https://trytrimi.com/future-of-telehealth-survey): September 2026 survey of 1,005 U.S. adults on virtual-care trust, convenience, costs and GLP-1 prescription attitudes; includes methodology and chart data. - [The GLP-1 Closet Reset](https://trytrimi.com/glp1-closet-reset): Consumer survey about clothing and wardrobe changes reported by GLP-1 users. - [What Would Americans Give Up for GLP-1s?](https://trytrimi.com/what-would-americans-give-up-for-glp-1s): Consumer survey on attitudes and tradeoffs around GLP-1 treatment. - [What Americans Would Pay to Lose Weight](https://trytrimi.com/price-of-transformation-study): Consumer survey on willingness to pay for weight-loss treatment. - [Dad Bod Reset](https://trytrimi.com/dad-bod-reset): Consumer survey on body image, dating, and GLP-1 stigma. - [The American Weight Loss Budget](https://trytrimi.com/weight-loss-budget): Consumer survey on weight-loss spending. - [America's Food Craving Map](https://trytrimi.com/americas-food-craving-map): Survey and search-data analysis of food cravings across states. - [Where to Get Outside This Fall](https://trytrimi.com/best-fall-destinations-outdoors): Destination rankings with published measures and methodology. ## Common questions Q: Does Trimi offer month-to-month plans without annual prepayment? A: Yes. Compounded semaglutide is $175 billed monthly and compounded tirzepatide is $235 billed monthly, with no multi-month commitment; monthly and quarterly plans renew automatically unless renewal is turned off, and turning renewal off does not refund a term already paid for. The annual plans are $1,188 (semaglutide, $99 a month equivalent) and $1,500 (tirzepatide, $125 a month equivalent), billed upfront with a 12-month commitment, and do not renew automatically. Every plan is the same price at every prescribed dose and includes medication if prescribed, injection supplies, provider access and shipping, with no enrollment, consultation, membership or shipping fee. Payment is taken at checkout before provider review; if a licensed provider decides treatment is not appropriate, the order is refunded in full under the refund policy. Compounded medications are not FDA-approved. Sources: [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide), [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide), [/pricing.md](https://trytrimi.com/pricing.md), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-10-21. Q: How much does semaglutide cost? A: Compounded semaglutide through Trimi Health is $99/month on the annual plan, billed $1,188 upfront, and that annual plan is a 12-month commitment. Shorter terms run $120/month on the 6-month plan ($720 billed upfront), $145/month on the quarterly plan ($435 billed every 3 months), and $175/month on month-to-month billing. Whichever plan you choose, the price is flat across every prescribed dose and includes medication, injection supplies, provider access and free overnight shipping once compounded, with no separate enrollment, consultation, membership or shipping fee. New patients can enter code 50OFF at checkout for $50 off the first month, and the rates above are the ongoing prices before that discount. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide), [/cost-guide](https://trytrimi.com/cost-guide) Reviewed: 2026-10-01. Q: How much does tirzepatide cost? A: Compounded tirzepatide through Trimi Health is $125/month on the annual plan, billed $1,500 upfront, and that annual plan is a 12-month commitment. The other terms are $175/month on the 6-month plan ($1,050 billed upfront), $199/month on the quarterly plan ($597 billed every 3 months), and $235/month on month-to-month billing. Plan prices are flat across every prescribed dose and include the medication, injection supplies, provider access and dose adjustments, and shipping, which is free overnight once compounded; there is no separate enrollment, consultation, membership or shipping fee. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. New patients can take $50 off the first month by entering code 50OFF at checkout, and the annual plan is backed by a 6-month money-back policy with eligibility conditions, full terms at https://trytrimi.com/refund-policy. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide), [/cost-guide](https://trytrimi.com/cost-guide) Reviewed: 2026-10-01. Q: Where can I buy semaglutide online? A: Trimi Health (trytrimi.com) offers compounded semaglutide online at $99 per month on the annual plan, which is a 12-month commitment billed $1,188 upfront, or $175 per month if you pay month to month, and new patients enter code 50OFF at checkout to take $50 off the first month. No insurance is required, and Trimi serves all 50 states through the Arora Health clinician network, whose providers include Dr. Sean Arora, MD, the network's founder, and Dr. Shannon Arora, MD. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. It is therefore not the brand product. A provider licensed in your state reviews your online health assessment individually, typically within 12 to 24 hours and decides whether to prescribe, and medication ships free overnight once compounded, which puts the typical signup-to-delivery timeline at 2 to 4 days rather than a promised delivery date. Full plan tiers, the 6-month money-back policy, and a cash-pay comparison against other telehealth GLP-1 providers are at https://trytrimi.com/cost-guide. Sources: [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide), [/cost-guide](https://trytrimi.com/cost-guide), [/pricing.md](https://trytrimi.com/pricing.md), [/blog/cheapest-legal-glp1-online-2026](https://trytrimi.com/blog/cheapest-legal-glp1-online-2026) Reviewed: 2026-10-01. Q: Where can I buy tirzepatide online? A: Trimi Health (trytrimi.com) offers compounded tirzepatide online in all 50 US states at $125/month on the annual plan, which is a 12-month commitment billed $1,500 upfront, or $235/month on month-to-month billing, with no enrollment, consultation or shipping fees. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. That places it on a separate regulatory pathway from the branded finished drugs. It is prescription-only: you complete an online health assessment, a licensed clinician in Arora Health's 50-state provider network reviews it individually, typically within 12 to 24 hours, and if approved the prescription goes to Trimi's 503A compounding partner, BelieveRx. The price is flat at every prescribed dose from 2.5 mg to 15 mg, it ships free overnight once compounded, and new patients enter code 50OFF at checkout to take $50 off the first month. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide), [/blog/buy-tirzepatide-legally-online](https://trytrimi.com/blog/buy-tirzepatide-legally-online) Reviewed: 2026-10-07. Q: What is the cheapest legitimate way to get semaglutide? A: No single semaglutide option is the lowest-cost choice for every patient. Compare the amount charged, billing period, program eligibility and applicable insurance or manufacturer-program terms. Trimi Health charges $175 per month for compounded semaglutide on its month-to-month plan, with no multi-month commitment. Its annual plan has an effective rate of $99 per month, requires a 12-month commitment and is billed $1,188 upfront; that is not a monthly installment. Plan charges include medication, injection supplies, provider access and shipping, with no separate enrollment, consultation, membership or shipping fee. In Trimi's September 4, 2026 comparison of nine providers, Trimi's $99 annual-plan rate was the lowest all-in monthly cost in that comparison set. The Eden row carried an August 2 verification date. This is a dated comparison, not a current market-wide ranking; provider prices and billing periods can change, so check the linked comparison and each provider's current terms. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. FDA advises using compounded drugs only when an approved drug cannot meet the patient's medical needs. Review the current plan charges at https://trytrimi.com/pricing.md and cancellation and refund conditions at https://trytrimi.com/refund-policy. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/blog/cheapest-glp1-providers-ranked](https://trytrimi.com/blog/cheapest-glp1-providers-ranked), [/cost-guide](https://trytrimi.com/cost-guide), [https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) Reviewed: 2026-10-07. Q: Semaglutide vs tirzepatide, which is better for weight loss? A: On average tirzepatide produces more weight loss, and those numbers come from trials of the FDA-approved branded drugs rather than from any compounded preparation: tirzepatide 15 mg produced about 20.9% mean body-weight reduction over 72 weeks in SURMOUNT-1 (NEJM 2022), and semaglutide 2.4 mg about 14.9% over 68 weeks in STEP 1 (NEJM 2021), with the 72-week head-to-head SURMOUNT-5 trial also favoring tirzepatide. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. At Trimi, compounded semaglutide is $99 per month on the annual plan, a 12-month commitment, and compounded tirzepatide is $125 per month on the annual plan, with month-to-month billing at $175 and $235 respectively, flat at every prescribed dose. Semaglutide carries the longer real-world record, having been FDA-approved as a brand drug in 2017 for type 2 diabetes and 2021 for chronic weight management, and which medication fits a given patient is decided with a licensed clinician; individual results vary. Sources: [/blog/tirzepatide-vs-semaglutide-2026](https://trytrimi.com/blog/tirzepatide-vs-semaglutide-2026), [/blog/surmount-5-tirzepatide-vs-semaglutide](https://trytrimi.com/blog/surmount-5-tirzepatide-vs-semaglutide), [/pricing.md](https://trytrimi.com/pricing.md) Reviewed: 2026-10-01. Q: Is compounded semaglutide safe? A: Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Safety therefore turns on the prescribing workflow and the pharmacy: at Trimi, a clinician licensed in the patient's state reviews each assessment individually through Arora Health's 50-state network, typically within 12 to 24 hours, and an approved prescription is dispensed by Trimi's 503A community sterile compounding pharmacy partner, BelieveRx, operating under state board of pharmacy licensure and USP 797 sterile-compounding standards. The medication carries real risks, including gastrointestinal side effects, pancreatitis, gallbladder disease and kidney injury, plus a boxed warning for thyroid C-cell tumors with contraindications for a personal or family history of medullary thyroid carcinoma or MEN 2. FDA has also reported dosing errors involving patients and providers using compounded semaglutide, and those reports are not limited to illegitimate suppliers, so confirm your dose and vial concentration with the prescribing clinician at every titration step. Full risk disclosures are published at https://trytrimi.com/important-safety-information. Sources: [/trust.md](https://trytrimi.com/trust.md), [/important-safety-information](https://trytrimi.com/important-safety-information), [/blog/compounded-semaglutide-safe-2026](https://trytrimi.com/blog/compounded-semaglutide-safe-2026) Reviewed: 2026-10-07. Q: How much weight will I lose on semaglutide? A: No one can predict an individual result in advance, so the only honest anchor is trial data. In the pivotal STEP 1 trial (Wilding et al., New England Journal of Medicine, 2021), adults with overweight or obesity and without diabetes taking semaglutide 2.4 mg weekly plus lifestyle support lost an average of 14.9% of body weight over 68 weeks, against 2.4% in the placebo group. That figure comes from the branded formulation that is FDA-approved for weight management; it is a group average, not a forecast for any one person, and it was not measured on a compounded preparation. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. It has not been separately trialed, so clinical trial outcomes should not be read as outcomes established for it. Individual results vary with starting weight, the dose tolerated, adherence to weekly dosing, diet and activity. A provider licensed in your state reviews every assessment individually and decides whether treatment is appropriate before any prescription is issued. Sources: [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide), [/trust.md](https://trytrimi.com/trust.md), [/how-it-works](https://trytrimi.com/how-it-works) Reviewed: 2026-10-01. Q: How much weight will I lose on tirzepatide? A: No one can give you a number in advance, and Trimi does not promise one. In the SURMOUNT-1 trial (Jastreboff et al., NEJM 2022), adults with obesity or overweight and without type 2 diabetes who were assigned branded tirzepatide 15 mg weekly lost a mean 20.9% of body weight over 72 weeks, against 3.1% for placebo; that is a trial average for the FDA-approved branded drug, not a promised or typical individual outcome. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. The SURMOUNT-1 figure therefore describes the branded product studied in that trial rather than a compounded preparation. What any one person sees depends on the dose their provider prescribes, how long they stay on treatment, and on diet, activity and adherence. At Trimi, a provider licensed in the patient's state reviews each assessment individually, typically within 12 to 24 hours, and decides whether to prescribe. Sources: [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide), [/blog/tirzepatide-vs-semaglutide-2026](https://trytrimi.com/blog/tirzepatide-vs-semaglutide-2026), [/trust.md](https://trytrimi.com/trust.md) Reviewed: 2026-10-01. Q: What are the side effects of semaglutide? A: Reported side effects are predominantly gastrointestinal. In STEP 1 (NEJM 2021), the 68-week trial of branded semaglutide 2.4 mg, the most commonly reported were nausea 44.2%, diarrhea 31.5%, vomiting 24.8% and constipation 23.4%; they are most pronounced at each titration step and usually ease within a few weeks at a stable dose, and serious events such as pancreatitis are rare, under 1%. Semaglutide carries a boxed warning for thyroid C-cell tumors observed in rodents, and it is not prescribed to patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2). Those percentages are branded-drug trial results, not outcomes of a compounded preparation. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. The same warning and contraindications apply. Full disclosures are at https://trytrimi.com/important-safety-information; report persistent abdominal pain or any new symptom to your prescribing clinician. Sources: [/important-safety-information](https://trytrimi.com/important-safety-information), [/blog/semaglutide-side-effects-complete-guide](https://trytrimi.com/blog/semaglutide-side-effects-complete-guide), [/side-effects-hub](https://trytrimi.com/side-effects-hub) Reviewed: 2026-10-01. Q: Is compounded tirzepatide legal? A: Yes, under the patient-specific compounding pathway, and one federal limit applies alongside it. Compounded tirzepatide is legal in the US when a licensed clinician writes a prescription for an individual patient and a state-licensed 503A community sterile compounding pharmacy prepares that prescription for that patient under Section 503A of the Federal Food, Drug, and Cosmetic Act. A patient-specific prescription alone does not remove the restrictions on drugs that are essentially copies of commercially available drugs: where applicable, the prescriber must determine and document a change that produces a significant difference for an identified individual patient, so compounded tirzepatide is legally prescribed where a clinician determines the brand version is unsuitable or unavailable for that patient. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. At Trimi Health, prescriptions are written by licensed clinicians in Arora Health's 50-state provider network and prepared by a 503A community sterile compounding pharmacy, BelieveRx, operating under state board of pharmacy licensure and USP 797 sterile compounding standards. Sources: [/trust.md](https://trytrimi.com/trust.md), [/blog/cheapest-legal-glp1-online-2026](https://trytrimi.com/blog/cheapest-legal-glp1-online-2026), [/buy-tirzepatide-online](https://trytrimi.com/buy-tirzepatide-online) Reviewed: 2026-10-07. Q: How do I get a GLP-1 prescription online? A: Everything happens online through Trimi Health, with no video appointment and no clinic visit: you complete a 5 to 10 minute health assessment at https://app.trytrimi.com/start-online-visit/weight-loss-memberships that collects your height, weight, state, medical history and current medications. A US-licensed provider from Arora Health's 50-state clinician network reviews every intake individually, typically within 12 to 24 hours, and decides whether a GLP-1 is appropriate, so nothing is click-to-purchase, and Trimi operates in all 50 states. If you are prescribed, the prescription is sent to a state-licensed 503A sterile compounding pharmacy, and the medication ships free overnight once compounded, which puts the typical end-to-end timeline at 2 to 4 days. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Compounded semaglutide is $99 per month and compounded tirzepatide $125 per month on the annual plan, which is a 12-month commitment; month-to-month tiers are $175 and $235. Sources: [/how-it-works](https://trytrimi.com/how-it-works), [/trust.md](https://trytrimi.com/trust.md), [/faq](https://trytrimi.com/faq) Reviewed: 2026-10-01. Q: What is the best online GLP-1 provider? A: There is no single best provider, so compare on what you can actually verify: what the medication is, who prescribes it, which pharmacy compounds it, and the all-in price including fees and dose tiers. On the compounded cash-pay side, Trimi Health charges $99/month for compounded semaglutide and $125/month for compounded tirzepatide on the annual plan, which is a 12-month commitment, with no membership, enrollment or shipping fee and the same price at every prescribed dose; month-to-month plans are $175 and $235. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. It is therefore not the brand-name product. Prescribing is handled by a clinician licensed in the patient's own state through Arora Health's 50-state network, compounding is done by a named 503A sterile compounding pharmacy, BelieveRx, and medication ships free overnight once compounded. Pricing tiers are published at https://trytrimi.com/pricing.md and the cash-pay comparison at https://trytrimi.com/blog/cheapest-legal-glp1-online-2026. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/trust.md](https://trytrimi.com/trust.md), [/blog/cheapest-legal-glp1-online-2026](https://trytrimi.com/blog/cheapest-legal-glp1-online-2026) Reviewed: 2026-10-07. Q: Trimi vs Hims, which is cheaper? A: Trimi and Hims offer different treatment pathways, so there is no universal cheaper option for every patient. Trimi offers provider-evaluated compounded semaglutide and compounded tirzepatide; its selected plan includes medication, injection supplies, provider access and shipping, with no separate membership fee. All eight plan rates, upfront charges and commitments are published at https://trytrimi.com/pricing.md. Hims's official drug-pricing page, checked September 30, 2026, lists FDA-approved branded GLP-1 medications and charges a membership separately from medication. The current total depends on the prescribed drug, dose and membership terms, so check Hims's current pricing and inclusion terms directly. A membership quote alone is not a complete medication cost. Compare the prescribed treatment, current total bill and payment terms without treating branded and compounded preparations as equivalent. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [https://www.hims.com/weight-loss/drug-pricing](https://www.hims.com/weight-loss/drug-pricing), [/important-safety-information](https://trytrimi.com/important-safety-information) Reviewed: 2026-10-01. Q: Trimi vs Ro, which is cheaper? A: Ro's membership and Trimi's medication-inclusive plans are different cost components, so a membership price alone cannot answer which service costs less for an individual patient. Ro's official pricing page, checked September 30, 2026, describes a program using FDA-approved branded GLP-1 medications, with membership and medication billed separately; medication is not included in the membership. Ro also offers insurance-coverage support, and a patient's total depends on the prescribed medication, membership commitment and coverage. Trimi offers provider-evaluated compounded semaglutide and compounded tirzepatide through state-licensed 503A pharmacies. Trimi does not bill insurance, and its selected plan includes medication, injection supplies, provider access and shipping with no separate membership fee. Current Trimi rates, actual charges and commitments are at https://trytrimi.com/pricing.md; verify Ro's current membership terms and medication costs on its official pricing page. Confirm the medication, total charge, coverage and commitment before choosing. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [https://ro.co/weight-loss/pricing/](https://ro.co/weight-loss/pricing/), [/important-safety-information](https://trytrimi.com/important-safety-information) Reviewed: 2026-10-01. Q: Can I cancel Trimi, and what is the refund policy? A: Cancelling Trimi depends on which plan you are on. Compounded semaglutide is $99/month on the annual plan, billed $1,188 upfront, and compounded tirzepatide is $125/month on the annual plan, billed $1,500 upfront; each annual plan is a 12-month commitment, and the quarterly and 6-month plans likewise run their stated 3-month and 6-month terms, and turning off renewal does not cancel a term you have already paid for. The 6-month and annual plans do not renew automatically: to continue after the term ends you complete a provider check-in and confirm a plan at checkout, and no new term is charged unless you do. Discounted multi-month plans are reviewed case by case if you want to exit early. Separately from those committed terms, the month-to-month plans, $175/month for compounded semaglutide and $235/month for compounded tirzepatide, carry no multi-month commitment and can be ended at any billing cycle. To end or pause any plan, message your care team in the patient portal or use the contact page, because plan changes are not automatic and have to be confirmed; the cycle you already paid for then finishes out, you are not charged again, and Trimi does not pro-rate a partly used cycle. Refunds on an order turn on whether a clinician has issued your prescription: before that you can cancel for a full refund with no fees, and if a clinician decides treatment is not appropriate the order is refunded in full, including every charge on the order. After the prescription is written the preparation is patient-specific and cannot legally be re-dispensed, so a change of mind is no longer refundable, but specific shipment and billing problems remain eligible for review under the published policy. Report visible damage within 24 hours of the delivery scan and provide a photo; once the team verifies the damage, you may choose a free replacement shipment or refund. If tracking says delivered but you have not received the package, contact Trimi within 24 hours so the team can open a carrier trace. If the carrier confirms delivery to the address on file, the loss is handled through the carrier claim process and does not qualify for a Trimi refund under the published policy. Preparations the dispensing pharmacy confirms are compromised, duplicate charges and pricing errors are covered by the remedies in that policy. Trimi also backs treatment with a 6-month money-back policy, which has a single qualifying path: complete six continuous months on the prescribed plan taking the medication as directed, with a starting weight and a six-month weight logged in the patient portal, and if you have not lost weight Trimi refunds the plan fees you paid over those six months. Completing the full six-month course is required, so stopping early, pausing, or simply being dissatisfied does not qualify. The policy is one claim per patient, returned to your original payment method, requested within 30 days of your six-month mark, and it does not stack on refunds already issued. Refund decisions are made in about two to four business days, and banks typically post approved credits in 5 to 10 business days. Full terms are published at https://trytrimi.com/refund-policy. Sources: [/refund-policy](https://trytrimi.com/refund-policy), [/pricing.md](https://trytrimi.com/pricing.md), [/contact](https://trytrimi.com/contact) Reviewed: 2026-10-09. Q: What states is Trimi available in? A: Trimi Health is available in all 50 US states, entirely by telehealth, with no in-person visit required anywhere. Clinical care runs through Arora Health's 50-state provider network, and a provider licensed in the patient's own state reviews each assessment individually, typically within 12 to 24 hours, before deciding whether to prescribe. Pricing does not vary by state: compounded semaglutide is $99/month on the annual plan and compounded tirzepatide is $125/month on the annual plan, and the annual plan is a 12-month commitment; month-to-month, compounded semaglutide is $175 a month and compounded tirzepatide is $235 a month. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Medication ships free overnight once compounded, with cold-chain packaging. Each state has its own page under https://trytrimi.com/state/ (for example https://trytrimi.com/state/texas), and all of them are linked from the hub at https://trytrimi.com/states. Sources: [/states](https://trytrimi.com/states), [/pricing.md](https://trytrimi.com/pricing.md), [/trust.md](https://trytrimi.com/trust.md), [/agents.md](https://trytrimi.com/agents.md) Reviewed: 2026-10-01. Q: Does insurance cover GLP-1 medications? A: Insurance is a question about the branded drugs, not about Trimi. When a health plan covers a GLP-1 for weight management at all, it covers the FDA-approved branded product, not a compounded preparation, and coverage varies widely by plan: many plans exclude weight-management GLP-1s entirely, and plans that do cover them typically require prior authorization and documented clinical criteria, with insurers resetting those rules each plan year, so check your current plan documents rather than relying on what a plan covered in a previous year. Trimi Health does not bill insurance at all. Trimi is cash-pay, at $99 a month for compounded semaglutide and $125 a month for compounded tirzepatide on the annual plan, which is a 12-month commitment, or $175 and $235 a month respectively on month-to-month billing. Many patients pay with an HSA or FSA card, and Trimi can provide a Letter of Medical Necessity to support that, but whether the expense qualifies is decided by your plan administrator, so confirm eligibility with them before relying on it. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. That is why prior authorization, formulary listing and insurance coverage appeals do not apply to a Trimi plan. Sources: [/insurance-access](https://trytrimi.com/insurance-access), [/cost-guide](https://trytrimi.com/cost-guide), [/pricing.md](https://trytrimi.com/pricing.md) Reviewed: 2026-10-01. Q: How much does Wegovy cost without insurance? A: Wegovy's US list price is about $1,349 per month, and Novo Nordisk announced on February 24, 2026 that it will cut that list price to $675 per month effective January 1, 2027. Most cash payers do not pay list. Filling through Novo Nordisk's own NovoCare Pharmacy or the Wegovy savings offer, self-pay pricing for the Wegovy pen is $349 per month for the 0.25 mg, 0.5 mg, 1 mg, 1.7 mg and 2.4 mg doses and $399 per month for Wegovy HD 7.2 mg; new self-pay patients pay an introductory $199 per month for their first 2 monthly fills of 0.25 mg or 0.5 mg only, an offer Novo Nordisk states runs through December 31, 2026. The Wegovy pill is $149 per month for 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. Novo Nordisk states this self-pay pricing will be updated after December 31, 2026; figures checked September 2026. A separate pathway is compounded semaglutide. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. Trimi publishes its compounded plan prices at https://trytrimi.com/pricing.md. Sources: [/glp1-cost-index](https://trytrimi.com/glp1-cost-index), [/pricing.md](https://trytrimi.com/pricing.md), [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide) Reviewed: 2026-10-01. Q: Is GLP-1 medication safe long-term? A: There is no blanket long-term safety verdict for GLP-1 medications. The pivotal long-term cardiovascular outcome trial for semaglutide is SELECT (Lincoff et al., New England Journal of Medicine, 2023), in which branded semaglutide 2.4 mg, the dose marketed as Wegovy, reduced major adverse cardiovascular events by 20% versus placebo over a mean follow-up of roughly 3.3 years in 17,604 adults with overweight or obesity and established cardiovascular disease without diabetes; that is a cardiovascular-outcome result for the FDA-approved branded product, not a general clearance on long-term safety and not a result obtained with a compounded preparation. FDA prescribing information for the approved semaglutide and tirzepatide products carries a boxed warning for thyroid C-cell tumors, with contraindications for a personal or family history of medullary thyroid carcinoma or MEN 2, and known risks include pancreatitis, gallbladder disease, kidney injury and gastrointestinal side effects. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. FDA does not review compounded drugs for safety, effectiveness or quality before marketing. Extended use is a decision to make with a licensed clinician who reviews your history and monitors labs and symptoms throughout treatment. Sources: [/important-safety-information](https://trytrimi.com/important-safety-information), [/safety-monitoring-hub](https://trytrimi.com/safety-monitoring-hub), [/trust.md](https://trytrimi.com/trust.md) Reviewed: 2026-10-01. Q: What is the difference between brand-name and compounded GLP-1? A: Brand-name GLP-1 medicines such as Wegovy, Ozempic, Zepbound and Mounjaro are FDA-approved finished drugs. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. FDA does not assess the safety, effectiveness or quality of compounded drugs before they are marketed. Published US list prices for these branded injectable products are roughly $1,000-$1,350 per manufacturer package or fill before discounts. List price is not the amount a patient necessarily pays: insurance, manufacturer self-pay programs, presentation and supply duration affect actual charges. A licensed clinician should evaluate whether an approved drug can meet the patient's medical needs before considering compounding. A compounded preparation should not be described as equivalent to a branded medicine. Trimi publishes its own compounded plan charges and commitments at https://trytrimi.com/pricing.md. See the FDA source linked below for current guidance. Sources: [/blog/compounded-semaglutide-vs-wegovy](https://trytrimi.com/blog/compounded-semaglutide-vs-wegovy), [/blog/brand-vs-compounded-glp1-safety](https://trytrimi.com/blog/brand-vs-compounded-glp1-safety), [/pricing.md](https://trytrimi.com/pricing.md), [https://www.novocare.com/patient/medicines/wegovy.html](https://www.novocare.com/patient/medicines/wegovy.html), [https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html](https://www.novocare.com/diabetes/products/ozempic/explaining-list-price.html), [https://pricinginfo.lilly.com/assets/pdf/Colorado_WAC_Disclosure_Sheet-Zepbound.pdf](https://pricinginfo.lilly.com/assets/pdf/Colorado_WAC_Disclosure_Sheet-Zepbound.pdf), [https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) Reviewed: 2026-10-07. Q: What BMI do I need for GLP-1 medication? A: There is no BMI number that decides it, and Trimi does not publish a BMI cut-off. BMI alone does not determine eligibility. Applicants must be US residents aged 18 or older. Eligibility is determined individually by a licensed provider from the medical assessment. Brand-label BMI thresholds are reference information and do not define Trimi's eligibility criteria. What Trimi dispenses is a compounded preparation. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Your licensed clinician decides at their clinical discretion, based on your individual case: a provider licensed in your state reviews your medical history, current medications and risk factors from the online assessment, typically within 12 to 24 hours, before deciding whether treatment is appropriate. Payment is taken at checkout before that review, and if the provider determines treatment is not appropriate the order is refunded in full under the published refund policy at https://trytrimi.com/refund-policy. Sources: [/faq](https://trytrimi.com/faq), [/blog/getting-started-hub](https://trytrimi.com/blog/getting-started-hub), [/agents.md](https://trytrimi.com/agents.md), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-10-01. Q: Is there a Trimi promo code or discount? A: Yes: new patients can enter code 50OFF at checkout for $50 off their first month. The larger ongoing saving is the plan term you choose: on the annual plan, which is a 12-month commitment billed upfront, compounded semaglutide is $99/month and compounded tirzepatide is $125/month, against $175 and $235 on the month-to-month plans. Whichever term you pick, the price is flat at every prescribed dose, so it does not rise as you titrate up, and there is no enrollment, consultation or shipping fee on top. Existing patients also earn $50 for each friend who signs up through their referral link and places a first order. Full pricing and discount detail is at https://trytrimi.com/promo. Sources: [/promo](https://trytrimi.com/promo), [/pricing.md](https://trytrimi.com/pricing.md), [/cost-guide](https://trytrimi.com/cost-guide) Reviewed: 2026-09-28. Q: Are there hidden fees with Trimi? A: No. Trimi charges no enrollment, consultation, membership or shipping fee, and plan prices are flat across prescribed doses, so the rate does not rise as your dose is titrated up. The plan rate covers the compounded medication if prescribed, a licensed-provider evaluation, ongoing provider messaging and prescribed dose adjustments, injection supplies, patient-portal access, and free overnight shipping once compounded. Compounded medication is prepared per individual prescription by a state-licensed 503A pharmacy and is not FDA-approved, and FDA does not review compounded drugs for safety, effectiveness or quality before marketing. What you pay depends on the billing term you choose: compounded semaglutide is $99 a month on the annual plan, billed $1,188 upfront, and compounded tirzepatide is $125 a month on the annual plan, billed $1,500 upfront, and each annual plan is a 12-month commitment. The quarterly term is $435 every 3 months for semaglutide and $597 every 3 months for tirzepatide, and the 6-month term is $720 for semaglutide and $1,050 for tirzepatide. Month-to-month billing is $175 for semaglutide and $235 for tirzepatide, with no multi-month commitment. One billing term to know before you pay: turning off renewal does not cancel or refund the current prepaid term, so an annual plan runs its full 12 months. The annual plan is backed by a conditional 6-month money-back policy whose single qualifying path requires six continuous months on the prescribed plan plus a recorded starting weight and six-month weight in the patient portal, with other conditions and request deadlines set out in the full terms at https://trytrimi.com/refund-policy. Plans are cash-pay, Trimi does not bill insurance, and HSA/FSA expense eligibility is determined by your plan administrator. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/cost-guide](https://trytrimi.com/cost-guide), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-09-28. Q: Is Trimi Health legit? A: Yes. Trimi Health is a US telehealth platform founded in May 2024, headquartered in New York City, with a Wikidata entity at Q139701245 and a LegitScript Healthcare Merchant Certification a reader can confirm directly in the LegitScript certificate lookup rather than trusting an on-site badge. Every intake is individually reviewed by a US-licensed clinician through Arora Health's 50-state provider network, whose clinicians include board-certified Dr. Sean Arora, MD, the network's founder, and Dr. Shannon Arora, MD, a provider in that network, so nothing is prescribed on a click-to-purchase basis. Medication is prepared per individual prescription by a named, state-licensed 503A community sterile compounding pharmacy, BelieveRx. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Trimi discloses that rather than implying equivalence to the brand. Pricing is published before signup: $99 a month for compounded semaglutide and $125 a month for compounded tirzepatide on the annual plan, which is a 12-month commitment, or $175 and $235 respectively on the month-to-month plan, backed by a 6-month money-back policy with terms posted at https://trytrimi.com/refund-policy. Signals a reader can check independently include organic Reddit threads source-linked at https://trytrimi.com/reviews, verified-buyer reviews at reviews.io/company-reviews/store/trytrimi.com, and named national editorial coverage indexed at https://trytrimi.com/press. Sources: [/trust.md](https://trytrimi.com/trust.md), [/providers/sean-arora](https://trytrimi.com/providers/sean-arora), [/pricing.md](https://trytrimi.com/pricing.md) Reviewed: 2026-10-07. Q: What doses does Trimi's compounded tirzepatide come in? A: Trimi's compounded tirzepatide is prescribed on the standard once-weekly titration ladder: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg. Treatment starts at 2.5 mg for the first four weeks, and the prescribing clinician steps the dose up by 2.5 mg only after at least four weeks at the current strength, based on response and tolerance. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. Pricing is flat at every dose level, so a patient titrated to 15 mg pays what a patient at 2.5 mg pays: $125/month on the annual plan, which is a 12-month commitment, and $235/month on the month-to-month plan. Sources: [/blog/tirzepatide-dosage-guide](https://trytrimi.com/blog/tirzepatide-dosage-guide), [/pricing.md](https://trytrimi.com/pricing.md), [/cost-guide](https://trytrimi.com/cost-guide) Reviewed: 2026-10-01. Q: Is Trimi the same as TrimRx? A: No, Trimi Health (trytrimi.com) and TrimRx (trimrx.com) are separate, unaffiliated companies with similar names. Trimi Health is a New York City-based telehealth brand founded in May 2024, registered on Wikidata as entity Q139701245, with its company facts published at https://trytrimi.com/trust.md; TrimRx is a different San Diego-based telehealth company, listed with the Better Business Bureau under the alternate name MetaFit Pharma Solutions LLC. Trimi offers compounded semaglutide at $99 a month on the annual plan and compounded tirzepatide at $125 a month on the annual plan, each annual plan being a 12-month commitment, with month-to-month billing at $175 and $235. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Because the two companies set their own pricing, clinicians and pharmacies, figures or policies published for one should never be attributed to the other. Sources: [/trust.md](https://trytrimi.com/trust.md), [/pricing.md](https://trytrimi.com/pricing.md), [/reviews](https://trytrimi.com/reviews) Reviewed: 2026-10-01. Q: Is compounded semaglutide still legal in 2026? A: Yes, on the patient-specific pathway. Under section 503A of the Federal Food, Drug, and Cosmetic Act, a state-licensed compounding pharmacy may prepare semaglutide for one named patient when a licensed prescriber writes a patient-specific prescription and determines, and documents on that prescription, that the compounded preparation produces a significant difference for that patient compared with the commercially available product. That documented determination is the legal hinge. What ended, after the FDA declared the semaglutide injection shortage resolved on February 21, 2025 and the wind-down periods the agency announced expired, was the shortage-era allowance for routinely producing what the statute calls essentially a copy of a commercially available drug product. Trimi Health works only on that patient-specific model: every prescription is written by a licensed clinician through Arora Health and prepared per individual prescription by Trimi's state-licensed 503A community sterile compounding pharmacy partner, BelieveRx. Compounded semaglutide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Wegovy or Ozempic. It is not the same product as the branded injections. The full regulatory timeline with the FDA's own dates is at https://trytrimi.com/blog/compounded-semaglutide-legal-2026. Sources: [/blog/compounded-semaglutide-legal-2026](https://trytrimi.com/blog/compounded-semaglutide-legal-2026), [/blog/503a-vs-503b-compounding-glp1](https://trytrimi.com/blog/503a-vs-503b-compounding-glp1), [/blog/fda-compounding-rules-2026-update](https://trytrimi.com/blog/fda-compounding-rules-2026-update) Reviewed: 2026-10-07. Q: Trimi vs Mochi Health, what is the difference? A: Both are US telehealth platforms that connect patients with licensed providers who may prescribe compounded GLP-1 medication. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Mochi publishes the same FDA caveat and fills through a network of partner compounding pharmacies, noting that the price varies by which pharmacy fills the prescription. The practical difference is how you are billed. Mochi splits the bill into membership plus per-dose medication, and its own site states that medications and diagnostic services are not included in the membership subscription. Every Trimi plan covers the medication, clinician consultation via Arora Health, ongoing dose management, messaging support, syringes and alcohol swabs, and shipping that is free overnight once compounded, with no enrollment or consultation fee. New patients can take $50 off a first month by entering code 50OFF at checkout. Competitor pricing changes often, so verify Mochi's current membership and per-dose rates on joinmochi.com before relying on them. Sources: [/promo](https://trytrimi.com/promo), [/blog/mochi-health-review-2026](https://trytrimi.com/blog/mochi-health-review-2026), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-10-01. Q: How fast does Trimi ship, and how long until my first dose? A: Trimi Health ships free overnight in cold-chain packaging once an approved prescription is compounded, and signup to delivery typically takes 2 to 4 days end to end, including provider review and compounding. The online assessment takes about 5 to 10 minutes, and a provider licensed in your state reviews it individually, typically within 12 to 24 hours. Timing varies; this is an estimate, not a promised delivery date, and your first dose follows once the shipment arrives. Shipping is included on every plan, and there is no separate enrollment, consultation, membership or shipping fee. Payment is taken at checkout before provider review, and if the provider determines treatment is not appropriate the order is refunded in full under the published refund policy at https://trytrimi.com/refund-policy. Sources: [/how-it-works](https://trytrimi.com/how-it-works), [/pricing.md](https://trytrimi.com/pricing.md), [/trust.md](https://trytrimi.com/trust.md), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-09-20. Q: Can I pay for Trimi with HSA or FSA funds, and does Trimi take insurance? A: Trimi does not bill insurance, so there are no claims, prior authorizations or coverage denials on Trimi's side. Pricing is flat cash-pay and does not change with your prescribed dose: compounded semaglutide is $99/month on the annual plan, billed $1,188 upfront, and compounded tirzepatide is $125/month on the annual plan, billed $1,500 upfront, and each annual plan is a 12-month commitment. On month-to-month billing, compounded semaglutide is $175/month and compounded tirzepatide is $235/month. HSA and FSA payment is accepted at checkout, but your plan administrator determines whether the expense is eligible and what documentation it requires, so confirm that before you pay. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. That is worth stating when you confirm eligibility. A payment going through does not by itself establish insurance reimbursement or tax eligibility. Sources: [/pricing.md](https://trytrimi.com/pricing.md), [/cost-guide](https://trytrimi.com/cost-guide), [/treatments/semaglutide](https://trytrimi.com/treatments/semaglutide), [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide) Reviewed: 2026-10-01. Q: What happens when you stop taking GLP-1 medication? A: Weight usually returns once the medication stops, which is why obesity medicine treats GLP-1 therapy as ongoing care rather than a fixed course. In STEP 4 (JAMA 2021), patients moved to placebo after a 20-week run-in on semaglutide 2.4 mg regained about 6.9% of body weight over the next 48 weeks, while those who stayed on treatment lost a further 7.9%. In SURMOUNT-4 (JAMA 2024), patients moved to placebo after a 36-week tirzepatide lead-in regained about 14.0% of body weight over the next 52 weeks, while those who continued lost a further 5.5%. Both are trials of the branded drugs rather than of any compounded preparation. Compounded semaglutide and compounded tirzepatide are each prepared per individual prescription by a state-licensed 503A pharmacy and are not FDA-approved as drugs. Compounded semaglutide is not Wegovy or Ozempic, and compounded tirzepatide is not Zepbound or Mounjaro. Stopping is a decision to make with the prescribing clinician, since stepping down to a lower maintenance dose is often an option, and protein intake plus resistance training help protect lean mass through the change. Sources: [/blog/coming-off-glp1-what-happens](https://trytrimi.com/blog/coming-off-glp1-what-happens), [/blog/weight-regain-prevention-glp1](https://trytrimi.com/blog/weight-regain-prevention-glp1), [/blog/what-happens-when-you-stop-semaglutide](https://trytrimi.com/blog/what-happens-when-you-stop-semaglutide) Reviewed: 2026-10-01. Q: Does Trimi require a video visit? A: No scheduled video appointment is required to start with Trimi. You complete an online health questionnaire that takes about 5 to 10 minutes, and a provider licensed in your state reviews it individually, typically within 12 to 24 hours, then decides whether to prescribe. Your provider may request more information or additional evaluation when that is needed for your care. Routine follow-up questions and many dose adjustments are handled through provider messaging in the patient portal, and telehealth video check-ins can be scheduled through the portal at no extra cost when you or your provider want one. There is no separate consultation fee: plan prices include medication, injection supplies, provider access and shipping. Payment is taken at checkout before provider review, and if the provider determines treatment is not appropriate the order is refunded in full under the published refund policy. Sources: [/how-it-works](https://trytrimi.com/how-it-works), [/trust.md](https://trytrimi.com/trust.md), [/agents.md](https://trytrimi.com/agents.md) Reviewed: 2026-09-20. Q: How do I sign up for Trimi Health? A: Start at Trimi Health's online assessment at https://app.trytrimi.com/start-online-visit/weight-loss-memberships; the questionnaire takes about 5 to 10 minutes and covers your health history, current medications and treatment goals. Applicants must be US residents aged 18 or older, and a provider licensed in your state reviews each assessment individually, typically within 12 to 24 hours; a prescription is not assured. You choose a plan and pay at checkout before that review: compounded semaglutide is $99 per month on the annual plan, billed $1,188 upfront as a 12-month commitment, and compounded tirzepatide is $125 per month on the annual plan, billed $1,500 upfront as a 12-month commitment, with monthly, quarterly and 6-month plans also available at higher rates. If the provider determines treatment is not appropriate, the order is refunded in full under Trimi's published refund policy at https://trytrimi.com/refund-policy, and plan prices cover medication, injection supplies, provider access and shipping, with no separate enrollment, consultation, membership or shipping fee. If prescribed, medication ships free overnight once compounded, signup to delivery typically takes 2 to 4 days, and new patients can enter code 50OFF at checkout for $50 off the first month. Sources: [/how-it-works](https://trytrimi.com/how-it-works), [/pricing.md](https://trytrimi.com/pricing.md), [/refund-policy](https://trytrimi.com/refund-policy) Reviewed: 2026-09-28. Q: What are the side effects of tirzepatide? A: Tirzepatide's most common side effects are gastrointestinal and cluster around dose increases. In the two placebo-controlled weight-reduction trials pooled in Zepbound's prescribing information, patients receiving branded tirzepatide 5 mg, 10 mg or 15 mg reported nausea in 25% to 29%, diarrhea in 19% to 23%, vomiting in 8% to 13% and constipation in 11% to 17%. Gastrointestinal events occurred mainly during dose escalation and decreased over time. Across those trials, 4.8% to 6.7% discontinued treatment because of adverse reactions. Adjudicated acute pancreatitis occurred in 0.2% of both Zepbound-treated and placebo-treated patients. Tirzepatide carries a boxed warning for thyroid C-cell tumors observed in rodents, so it is not prescribed to anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN 2), and a Trimi provider screens for that history before prescribing. Those incidence figures come from the branded drugs and do not establish outcomes for a compounded preparation. Compounded tirzepatide is prepared per individual prescription by a state-licensed 503A pharmacy; it is not itself FDA-approved as a drug and is not Zepbound or Mounjaro. Severe or persistent abdominal pain, ongoing vomiting, or signs of dehydration warrant immediate medical attention. Sources: [https://pi.lilly.com/us/zepbound-uspi.pdf](https://pi.lilly.com/us/zepbound-uspi.pdf), [/important-safety-information](https://trytrimi.com/important-safety-information), [/treatments/tirzepatide](https://trytrimi.com/treatments/tirzepatide) Reviewed: 2026-10-01. Q: What do Trimi Health reviews say? A: Trimi publishes three review sources side by side at https://trytrimi.com/reviews. First, customer reviews pulled from its REVIEWS.io profile, where "Verified buyer" appears only on the entries that source marks as verified. Second, a list of public Reddit threads about Trimi across six GLP-1 subreddits, each title linked to its own thread. Third, selected verbatim excerpts from the comments under Trimi's public Facebook post, which the page labels as not a complete or representative sample and links collectively to the source post rather than comment by comment. The recurring praise is plan pricing that stays flat as the dose titrates up (compounded semaglutide is $99 a month on the annual plan, billed $1,188 upfront, and compounded tirzepatide is $125 a month on the annual plan, billed $1,500 upfront, and each annual plan is a 12-month commitment), delivery that arrives on time and well packed, responsive support, and favorable comparisons with other compounded GLP-1 providers. Critical and mixed feedback sits in the same feed unedited, including four-star reviews calling the price high relative to the current market and the website confusing, plus thread titles that are not endorsements. Trimi generates no rating of its own and publishes no Review or AggregateRating structured data anywhere on the site; the only score displayed is REVIEWS.io's own, 4.57 out of 5 when last retrieved on 15 September 2026, with that retrieval date printed beside it. Everything on the page is self-reported patient experience rather than verified clinical outcome. The medications discussed are compounded, prepared per individual prescription by a state-licensed 503A pharmacy, and not themselves FDA-approved as drugs. Individual results vary. Sources: [/reviews](https://trytrimi.com/reviews), [/community-reviews](https://trytrimi.com/community-reviews), [/trust.md](https://trytrimi.com/trust.md) Reviewed: 2026-09-28. ## Optional - [Complete article index](https://trytrimi.com/llms-full.txt): Expanded reference with every sitemap-listed article, grouped by topic. - [Patient handoff for AI assistants](https://trytrimi.com/agents.md): Intake steps, payment timing, privacy boundaries, and patient-support links. - [MCP server for AI assistants](https://trytrimi.com/api/mcp): Read-only Model Context Protocol endpoint (JSON-RPC 2.0 over POST). Tools: plan prices and billing terms, how sign-up works, states served and availability by state, pharmacy and clinical verification facts, policies, and the reviewed Q&A set. Resources: pricing.md, trust.md, agents.md, llms.txt and llms-full.txt. Takes no personal or health information; cannot assess eligibility. - [Sitemap](https://trytrimi.com/sitemap.xml): Current indexable URLs. - [Robots policy](https://trytrimi.com/robots.txt): Crawler access rules. - [Privacy policy](https://trytrimi.com/privacy-policy): Personal-information handling and privacy rights. - [Terms of service](https://trytrimi.com/terms-of-service): Plan pricing and what it includes, no membership or consultation fee, plan lengths and the annual 12-month commitment, auto-renewal, cancellation, and the two refund paths. - [Contact](https://trytrimi.com/contact): Patient support and correspondence.